Clay Davis @clay_cd

sociology PhD candidate and Mellon cluster fellow in science studies at Northwestern. see my new paper in @Soc_Stud_Sci claydav.is Evanston, IL Joined December 2012

Tweets

10
Followers

137
Following

289
Likes

123

Clay Davis @clay_cd

2 years ago

@bengrossbg Try using an e-reader and setting the font and size to exactly what makes your eyes comfortable. I know I know there’s nothing like a paper book but in practice it makes a slight but significant difference

0 0 2 79 0

View Details

Clay Davis @clay_cd

2 years ago

@lionel_trolling Polls represent epistemological (having to do with the likeliness of an event given relevant evidence) rather than aleatory (having to do with stochastic events like coin flips) probability, two distinct concepts that were conflated starting in the 17th century (see Ian Hacking)

0 0 0 33 0

View Details

Clay Davis @clay_cd

2 years ago

deeply honored to have my recent work recognized by @ASA_SKAT!😃It was a lovely opportunity to connect with @zephoria, @michsmirnova, and other STS scholars not on Twitter. a sincere thank you to all the members of the award committee!

ASA SKAT Section @ASA_SKAT

2 years ago

@lulusouzaleao @UChicagoPress @UMSociology @DromiShai @heavenwasblue @HarvardSoc @HunterSociology @PrincetonUPress @jdvasqueza @AU_SIS @lucyparsonslabs @BigDataSoc @davidecarpano Winner of the Hacker-Mullins Student Paper Award is Clay Davis's "The routinization of lay expertise: A diachronic account of the invention and stabilization of an open-source artificial pancreas" Link🔗: doi.org/10.1177/030631… (9/9)

0 0 5 513 0

0 1 3 250 0

View Details

Clay Davis @clay_cd

5 years ago

@mnolangray @amandakhurley Why would you control for state-level subsidies? Seems like an important part of the political effect you’re trying to capture

0 0 7 0 0

View Details

Clay Davis @clay_cd

6 years ago

COVID-19 has strained the FDA to quickly evaluate new drugs and vaccines. But the tension between urgency and safety is not new—Can COVID-19 policymakers learn from the HIV epidemic? I trace the FDA’s history and offer a path toward transparency and trust: bit.ly/3ajx95t

0 0 0 0 0

View Details

Clay Davis @clay_cd

6 years ago

@Marc_Alessi @Soc_Stud_Sci Thank you Marc!

0 0 0 0 0

View Details

Clay Davis @clay_cd

6 years ago

Grappling with adherence, risk, and efficacy is a central problem of HIV PrEP public health policy. How have these (often contested) concepts been informed by two decades of PrEP clinical research? My new paper in @Soc_Stud_Sci: journals.sagepub.com/doi/10.1177/03…

1 2 10 0 0

View Details

Clay Davis @clay_cd

6 years ago

@benvyle @Soc_Stud_Sci absolutely! Injectable PrEP didn't make it into the paper but I suspect it's a good example of how adherence (concealed in efficacy) can determine to whom an intervention is targeted.